December 24th 2025, 10:00pm
CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.
December 24th 2025, 8:00pm
All I can say is thank you Healthwell Foundation for giving our brother life, and for giving our whole family unit life. Because of you, we can keep on keeping on.
December 24th 2025, 4:00pm
Ceralasertib plus Imfinzi failed to improve overall survival versus docetaxel in a phase 3 study of previously treated non-small cell lung cancer.
December 24th 2025, 9:00pm
As kidney cancer survival improves, more patients report cognitive changes affecting memory, fatigue, and overall mental clarity
December 24th 2025, 6:00pm
Christmas is my favorite time of year. Since my child was diagnosed with cancer, however, the only gift I want is one more Christmas with her being here.
December 24th 2025, 5:00pm
Trodelvy elicited fewer side effects that led to dose reduction compared with chemotherapy in previously untreated triple-negative breast cancer.
December 24th 2025, 2:00pm
Jace Yawnick explained why a support system is essential for patients with cancer.
December 23rd 2025, 6:00pm
I have been diagnosed with breast cancer for the third time, and I find it interesting how the places where I seek support have changed over time.
December 23rd 2025, 10:00pm
Clinical trials give patients with metastatic breast cancer access to new treatments, all while being closely monitored and moving the landscape forward.
December 23rd 2025, 9:00pm
Trodelvy led to fewer side effects that required dose reductions or stopping treatment vs chemo among previously untreated triple-negative breast cancer.
Momentum and Meaning at the 2025 American Society of Hematology Meeting
We Wish You a Merry Christmas
Ceralasertib-Imfinzi Misses Survival End Point in Lung Cancer Trial
Cognitive Health Gains Focus in Kidney Cancer Survivorship